Colchicine treatment for newly diagnosed thyroid inflammation
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether colchicine, a medication that reduces inflammation, can help people recently diagnosed with Hashimoto's thyroiditis or subacute thyroiditis (two types of thyroid inflammation). Researchers want to see if it improves symptoms and thyroid function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You were recently diagnosed with Hashimoto's thyroiditis or subacute thyroiditis (confirmed by blood tests, physical exam, and ultrasound)
- You are not pregnant, planning to become pregnant, or breastfeeding
- Your kidneys and liver are working reasonably well
- You are not currently taking corticosteroid medications (or stopped at least 30 days ago)
- You do not have an active serious infection or blood cell problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This trial tests if colchicine, an anti-inflammatory medicine, can help people who recently had a heart attack. It looks for markers in your blood to see who might benefit most.
This trial tests whether colchicine (a medicine that reduces inflammation) improves outcomes in people with acute myocarditis soon after symptoms start. Half of participants get colchicine and half get a placebo to see which works better.
This trial tests if the anti-inflammatory drug colchicine can help people hospitalized with acute heart failure and a weak heart pump. It may benefit those with elevated inflammation markers.
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
Hear when a new Hashimoto Thyroiditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.